Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<01099.HK> - Sinopharm Group Co. Ltd.

 
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
SINOPHARM 400 6.43 0.7153 3.179 0.9537
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2024-11-15　作為國藥集團核心子公司之一，國藥控股連續第七年以中央企業交易團成員身份再赴「進博之約」，與多家世界領先生命科學及醫療器械企業續寫合作新篇章，達成意向簽約總金額超９．５億美元。此外，國藥控股先後與吉利德科學、諾和諾德簽訂合作框架協議，啟動合作新篇章。共贏之約、共享未來，國藥控股正攜手全球合作伙伴，開展廣泛深入交流，不斷引進國際先進技術和產品，為有幫帶動醫療事業高質量發展，增進人民健康福祉貢獻力量。
 
2024-12-06　國藥控股股權有限公司作為中國最大的藥品、醫療保健產品、醫療器械龍頭分銷商和零售商，以及領先的供給鏈服務提供商，類似業務覆蓋全國范圍，在國內處於領先的地位。同一時間，作為戰略儲備單位，國藥控股憑借其完善的供給鏈，在保障國家公共衛生安全方面發揮著至關主要的作用。國藥控股全球采購與供給鏈服務中心是國藥控股核心業務管理和運營平台，承擔著國藥控股的大部分戰略品種的全國進口、采購及分銷任務，及全國統一服務功能。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 01-13 09:30 18846.2 ▼ 218.14 ▼ 1.14%
SINOPHARM 05-08 10:22 20.85 ▲ 20.85 ▲ ∞%
≫More
 
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.